v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash Flows from Operating Activities:    
Net income $ 4,412,993 $ 7,425,515
Adjustments to reconcile net income to net cash provided by (used for) operating activities:    
Change in fair value of warrant liability derivative (2,038,793) (246,125)
Change in fair value of convertible note derivative (382,154) (3,990,385)
Change in fair value of long-term and short-term note derivative (103,185) (11,585,286)
Change in fair value of contingent guarantee 839,775
Change in fair value of debenture derivative (5,482)
Change in fair value of secured convertible note 1,078,855
Change in fair value of merger financing (63,696) (10,670)
Change in fair value of earnout liability (10,680,000) (1,068,000)
Change in fair value of Winston & Strawn agreement (1,799,545) 59,286
Change in fair value of stock payable (232,793)
Change in fair value of Tau agreement (334,549) 707,547
Loss on settlement on Winston & Strawn agreement 570,300
Late fee paid in shares to sellers 16,340
Non-cash interest in expense on financial instruments 3,646,719 6,178,848
Transaction cost attributed to 2025 warrants 865,659
Realized gain on Tau agreement (19,064)
Commission on Tau agreement 81,191
Excise tax penalties and interest 483,027
Consulting expense paid with stock 434,114
Stock based compensation 2,483,600 41,982
Bank acquisition deposit write off 91,200
Depreciation expense 13,707
Amortization of intangibles 1,059,650 1,010,519
Allowance for bad debt 12,754 7,322
Net lease payments 7,125 (1,313)
Changes in operating assets and liabilities:    
Cash deposits with clearing organization & other B/Ds (1,247,500)
Receivables from brokers & dealers (73,400) 634,244
Receivables from customers (475,708) 420,242
Receivables from others 8,700 11,741
Advances & prepaid expenses 307,273 (291,373)
Other assets (335,686) 2,500
Payables to customers (1,046,209) (2,080,762)
Payables to officers & directors (140,810) 270,657
Payable to brokers & dealers 2,695,713 7,515
Accounts payable and accrued expenses (3,582,020) 598,621
Commissions and payroll taxes payable (27,369) (59,753)
Deferred taxes (246,310) (370,205)
Trading deposits (34)
Net cash used for operating activities (4,998,995) (1,053,950)
Cash Flows from Investing Activities    
Cash paid for purchase of Pacsquare (125,000)
Cash paid for bank acquisition deposit (65,000)
Net cash used for investing activities (65,000) (125,000)
Cash Flows from Financing Activities    
Proceeds from Equity SPA 5,850,000
Transaction cost paid with Equity SPA (1,228,500)
Proceeds from Secured Convertible Notes 10,000,000
Transaction cost paid with Security Convertible Notes (25,000)
Proceeds from Tau agreement 1,437,381
Proceeds from Convertible Notes, net of transaction cost 4,700,000
Payment on Convertible Notes (1,850,000)
Proceeds from debenture, net of transaction cost 490,000
Proceeds from third party advances 200,000
Subordinated debt payments (20,000)
Payment on Winston & Strawn settlement agreement (1,000,000)
Repayment of promissory notes (509,721) (56,519)
Net cash provided by financing activities 16,626,779 1,360,862
Net Change in Cash 11,562,784 181,912
Cash at beginning of period 29,609,219 27,307,886
Cash at end of period 41,172,003 27,489,798
Supplementary cash flow information:    
Cash paid for interest 56,625 24,375
Cash paid for income taxes 85,784
Supplemental cash flow information non-cash investing and financing activities:    
Decrease in goodwill due to change in deferred tax liability 1,564,200
Initial shares issued under Tau agreement 205,238
Value of shares transferred by related parties to settle obligations 2,412,930
Shares issued to related party for settlement of accounts payable 803,860
Receivable from shares advanced under Tau agreement 205,238
Shares issued for Commercial Bancorp acquisition extension 43,645
Shares issued for conversion of principal and interest on long-term note 1,014,055 1,229,428
Shares issued for stock payable 27,100
Initial value of derivative included in merger financing 113,044
Promissory note issued under insurance premium 408,686 489,381
Reversal of excise tax 2,611,618
Convertible Notes transferred to Equity SPA 4,150,000
Initial value of warrants allocated for Equity SPA 5,540,000
Initial value of warrant issued as transaction cost under Equity SPA 334,062
Shares issued for Winston & Strawn settlement agreement 260,700
Shares issued for non-cash exercise of 2025 Warrants 1,094,669
Right-of-use assets obtained in exchange for new operating lease liabilities 537,863
Chardan Note [Member]    
Supplemental cash flow information non-cash investing and financing activities:    
Initial value of derivative included debenture derivative 959,764 4,525,000
Short-Term Debt [Member]    
Supplemental cash flow information non-cash investing and financing activities:    
Initial value of derivative included debenture derivative 5,366,979
Merger Financing [Member]    
Supplemental cash flow information non-cash investing and financing activities:    
Initial value of derivative included debenture derivative 1,666,382 108,813
Secured Debt [Member]    
Supplemental cash flow information non-cash investing and financing activities:    
Initial value of derivative included debenture derivative 9,591,650 509,549
Notes Payable, Other Payables [Member]    
Supplemental cash flow information non-cash investing and financing activities:    
Initial value of derivative included debenture derivative 763,384
Series Convertible Debentures [Member]    
Supplemental cash flow information non-cash investing and financing activities:    
Initial value of derivative included debenture derivative 352,067
Convertible Promissory Notes [Member]    
Supplemental cash flow information non-cash investing and financing activities:    
Initial value of derivative included debenture derivative 382,154
Pacsquare [Member]    
Supplemental cash flow information non-cash investing and financing activities:    
Shares issued to related party for settlement of accounts payable $ 77,300